Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FJ3G3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,229
Award facts
- Contract value 100% obligated
- $25,229.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,229.22 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This is a firm fixed-price delivery order with an ultimate completion date of November 18, 2025, and was awarded on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Mounjaro is a diabetes medication used for glycemic control, reflecting the pharmaceutical distributor's established role in supplying specialty medications to military and federal healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency's medical supply chain, with a robust portfolio of delivery orders across multiple therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and other specialized healthcare commodities. The DLA Troop Support Medical IDC enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency worldwide, with the contract vehicle supporting flexible procurement across multiple customer agencies.
Quick answers
Who was awarded contract SPE2DR26FJ3G3?
SPE2DR26FJ3G3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FJ3G3 worth?
The government has obligated $25,229 on SPE2DR26FJ3G3.
Is contract SPE2DR26FJ3G3 an order under another contract?
Yes. SPE2DR26FJ3G3 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ3G3 competed?
The extent of competition for SPE2DR26FJ3G3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award